Stocks
Nuo Therapeutics, Inc.AURX
OQBHealthcareBiotechnology$1.30
Price as of · delayed, not real-time
A biotechnology company focused on developing and commercializing autologous cell therapies for wound healing and tissue repair. Its lead product, Aurix, is a point-of-care autologous platelet-rich plasma device used in chronic wound management. Investors track the company for its regulatory milestones and commercial progress in the regenerative medicine market.
52W Range: $0.77-$2.92
Congressional Interest in Nuo Therapeutics, Inc. (AURX)
No congressional trades have been disclosed for Nuo Therapeutics, Inc. (AURX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AURX?
No congressional trades found for this stock.